Answers are grounded in this paper and cite their sources.
Determining the drivers of diversity in plant pathogen populations is a critical for developing effective management strategies. Sclerotinia sclerotiorum, a cosmopolitan fungus infecting over 400 plant species, causes considerable yield and economic losses worldwide. However, longstanding questions remain about the association between genetic and phenotypic variation in this pathogen, leaving the drivers of its diversification unresolved. Here, we characterized the diversity of S. sclerotiorum isolates from the United States in a global context and tested the hypothesis that phylogenetic relatedness structures phenotypic variation among isolates. Genome-wide variant analysis resolved US isolates into several distinct lineages, with short within-lineage branch lengths consistent with recent common ancestry or clonal propagation. Population structure analysis confirmed two major global clusters, one composed predominantly of Australian isolates and the other largely of isolates from the rest of the world, including the US. Notably, several US isolates grouped within the Australian cluster, suggesting historical intercontinental movement of this pathogen. Contrary to our expectations, isolate relatedness was more strongly associated with data such as host, geographic origin, and year of collection compared with morphological variation, suggesting that phenotypic variation segregates independently of phylogenetic structure. Instead, the distribution of phenotypic variation primarily reflected two trade-offs: rapid radial growth with shorter sclerotial development versus slower growth with prolonged sclerotial development, and the production of many small sclerotia versus fewer larger ones. Together, our results shed light on the complex relationships between phenotypic, ecological, and phylogenetic variation and bring us one step closer to predicting how diversity is structured in natural populations of a global fungal pathogen.
No takes yet. Share an insight, caveat, or question.
Sharma et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: